Use access key #2 to skip to page content.
$6.35 -0.14 (-2.16%)
5/16/2008 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating:
*****

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

View All Commentary (EXEL)

Recs

1

Avatar BRADYstocks (< 20) Submitted: 2/25/08 9:26 PM : Underperform Start Price: $6.16 EXEL Score: 1.24

This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.

Report this Post Replies: 0 | Reply

Featured Broker Partners